SCHEMBL10123167

SCHEMBL10123167

c1ccc2c(c1)ncc1nc3n(c12)CCOCC3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 5/20 0.43
GAA P10253 4/20 0.43
HPGD P15428 4/20 0.43
HSD17B10 Q99714 3/20 0.43
GLA P06280 3/20 0.43
PTK2 Q05397 1/20 0.43
MAPT P10636 1/20 0.40
ALOX15 P16050 2/20 0.40
USP2 O75604 1/20 0.40
CYP1A2 P05177 1/20 0.40
BCHE P06276 1/20 0.40
CFTR P13569 1/20 0.40
ACHE P22303 1/20 0.40
HKDC1 Q2TB90 1/20 0.40
GOPC Q9HD26 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
METAP1 P53582 2/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12888417 0.78 NCF1 (0.43) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL10123163 0.76 KDM4E (0.48) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL204000 0.76 KDM4E (0.39) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL10123166 0.74 POLB (0.37) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL12020770 0.72 KDM4E (0.33) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL12201431 0.72 KDM4E (0.33) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL10237145 0.72 KDM4E (0.36) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL202424 0.71 KDM4E (0.38) KDM4EALDH1A1GAAHPGDHSD17B10
Hydrochloric Acid SCHEMBL1232977 0.71 CHRNB2 (0.40) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL12201376 0.70 TLR7 (0.35) KDM4EALDH1A1GAAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093390-B2 Substituted fused [1,2]imidazo[4,5-C] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-10 US disclosed
US-20090005371-A1 Substituted Fused [1,2]Imidazo[4,5-C] Ring Compounds and Methods 3M INNOVATIVE PROPERTIES COMPANY 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005371-A1 Substituted Fused [1,2]Imidazo[4,5-C] Ring Compounds and Methods IL2, IFNG, IL4 KDM4E 3148/4885ALDH1A1 890/4885GAA 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.